NGM BIOPHARMACEUTICALS INC (NGM) has 217 open-market insider trades by 27 insiders since 2019. The most active filer is David V. Goeddel, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| David V. Goeddel | Dir10% Owner | — | 54 | $119.3M | 2024-04-05 |
| Peter Svennilson | Dir10% Owner | — | 39 | $87.3M | 2022-12-12 |
| Merck & Co., Inc. | 10% Owner | — | 1 | $65.9M | 2019-04-08 |
| Column GROUP L P | Dir10% Owner | — | 15 | $20.3M | 2023-11-16 |
| Jin-long Chen | CSO | — | 23 | $14.5M | 2023-03-02 |
| Tim Kutzkey | Dir10% Owner | — | 10 | $13.1M | 2024-04-05 |
| Ponoi Management, LLC | Dir10% Owner | — | 7 | $7.7M | 2022-06-09 |
| Column GROUP Iii-a, L.P. | Dir10% Owner | — | 7 | $6.6M | 2023-01-23 |
| Ponoi Capital II, LP | Dir10% Owner | — | 7 | $5.2M | 2023-01-30 |
| Column GROUP Gp, L.P. | Dir10% Owner | — | 5 | $3.4M | 2023-01-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Column GROUP L P | Director & 10% | Buy | $16K | 2023-11-15 |
| David V. Goeddel | Director & 10% | Buy | $18K | 2023-11-15 |
| Ponoi Capital II, LP | 10% | Buy | $38K | 2023-01-30 |
| David V. Goeddel | Director & 10% Owner | Buy | $921K | 2023-01-30 |
| Ponoi II Management, LLC | 10% | Buy | $50K | 2023-01-23 |
| TCG Opportunity III GP, LLC | 10% | Buy | $3K |
Companies that share insiders with NGM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-01-20 |
| David V. Goeddel | Director & 10% Owner | Buy | $191K | 2023-01-19 |
| Jin-long Chen | CSO | Sell | $876K | 2023-01-17 |
| Column GROUP Ii, L.P. | 10% | Buy | $27K | 2023-01-12 |
| Column Group IV-A, LP | 10% | Buy | $484K | 2023-01-10 |
| David V. Goeddel | Director & 10% Owner | Buy | $2.0M | 2023-01-10 |
| David V. Goeddel | Director & 10% | Buy | $1K | 2022-12-12 |